Business / Finance

RSS

Decade Sunshine, 3SBio enter Merger Agreement

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.

10 Feb 2013

KFH/HP 2012 combined total operating revenue increases to $50.6 billion

Kaiser Foundation Hospitals, Kaiser Foundation Health Plan, Inc., and their subsidiaries (KFH/HP) reported today that combined total operating revenue for 2012 was $50.6 billion, compared to $47.9 billion in 2011.

10 Feb 2013

Taro, Sun Pharma mutually agree to terminate merger agreement

Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a cash payment of $39.50 per share upon the closing of the merger.

10 Feb 2013

CEL-SCI reports net loss of $2,310,246 for fiscal quarter ended December 31, 2012

CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.

10 Feb 2013

Care Investment Trust enters joint venture with affiliates of Calamar

Care Investment Trust Inc., a real estate investment company that invests in healthcare and seniors-related real estate, today announced that effective as of February 1, 2013, it entered into a joint venture with affiliates of Calamar Enterprises, Inc., owned 75% by affiliates of Care and 25% by affiliates of Calamar, for the acquisition of two senior apartment communities from affiliates of Calamar with an aggregate value of $23.3 million.

10 Feb 2013

Accuray announces pricing of $100 million convertible senior notes due 2018

Accuray Incorporated today announced the pricing of its offering of $100 million aggregate principal amount of 3.50% convertible senior notes due 2018.

10 Feb 2013

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2012.

9 Feb 2013

Gilead Sciences acquires YM BioSciences

Gilead Sciences, Inc. today announced that it has completed its acquisition of YM BioSciences Inc.

9 Feb 2013

Crothall Healthcare announces acquisition of Coppell

Crothall Healthcare of Wayne, Pennsylvania, announced its acquisition of Coppell, Texas-based CREST Services, a national leader in medical equipment maintenance. The transaction was finalized on December 20, 2012.

7 Feb 2013

Lannett second quarter net sales increase 32% to $36.6 million

Lannett Company, Inc. today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 second quarter ended December 31, 2012, compared with the prior year period.

7 Feb 2013

Misonix revenue increases 19% to $8.0M for six months ended December 31, 2012

Misonix, Inc., a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, cranial maxillo – facial surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today reported financial results for the six-months and the second quarter of fiscal year 2013, ended December 31, 2012.

7 Feb 2013

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.

7 Feb 2013

Greater Boston Business Council honors UMass Medical School's Work Without Limits program

The Greater Boston Business Council honored UMass Medical School's Work Without Limits program with its Outstanding Business Member of the Year Award for Excellence in Community Service at its recent annual awards ceremony.

6 Feb 2013

Stericycle fourth quarter revenues increase 12.8% to $503.6 million

Stericycle, Inc., today reported financial results for the fourth quarter and full year of 2012.

6 Feb 2013

Genomic Health fourth quarter total revenue increases to $60.4 million

Genomic Health, Inc. today reported financial results and business progress for the quarter and year ended December 31, 2012.

6 Feb 2013

Genpact announces acquisition of JAWOOD

Genpact Limited, a global leader in business process management and technology services, today announces that it has acquired JAWOOD, a leading provider of business services to the healthcare payer industry.

6 Feb 2013

Elan agrees to restructure Tysabri collaboration with Biogen Idec

Elan Corporation, plc today announced that it has agreed to restructure the Tysabri® collaboration with Biogen Idec.

6 Feb 2013

Aflac fourth quarter revenues increase 6.6% to $6.4 billion

Aflac Incorporated today reported its fourth quarter results. Reflecting the weaker yen/dollar exchange rate, revenues rose 6.6% to $6.4 billion in the fourth quarter of 2012, compared with $6.0 billion in the fourth quarter of 2011. Net earnings were $581 million, or $1.24 per diluted share, compared with $538 million, or $1.15 per share, a year ago.

6 Feb 2013

USANA Health Sciences’ fourth quarter net sales increase 15.5% to $168.5 million

USANA Health Sciences, Inc. today announced record financial results for its fiscal fourth quarter and full-year ended December 29, 2012.

6 Feb 2013

Tenet completes $850 million Senior Secured Notes offering

Tenet Healthcare Corporation announced today the successful completion of its previously announced private offering of $850 million aggregate principal amount of its 4.50% Senior Secured Notes due 2021.

6 Feb 2013